Premium
Effect of prostaglandin E in multiple experimental models: V. Effect on tumor/host interaction
Author(s) -
Waymack J. Paul,
Chance William T.
Publication year - 1990
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930450210
Subject(s) - prostaglandin e , immunosuppression , medicine , prostaglandin e2 , endocrinology , metabolism , prostaglandin , immune system , cancer research , immunology
Prostaglandin E (PGE) has long been incriminated as a cause of the immunosuppression seen in cancer patients and for the increased rates of tumor growth due to the impairment of the immunologic response to the tumor. We have investigated the effect of PGE on tumor‐host interaction by utilizing a parenterally administered long‐acting PGE derivative, 16,16‐dimethyl‐prostaglandin E (dPGE). Administration of dPGE was found to decrease the rate of tumor growth but at a cost of decreasing tumor‐free body mass. The dPGE did not alter resting metabolic rates but did alter some parts of brain dopamine metabolism and significantly decreased the serum level of multiple amino acids. In conclusion, elevated PGE levels may significantly alter metabolism in tumor patients.